REGENXBIO Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
REGENXBIO Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • REGENXBIO Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $121M.
  • REGENXBIO Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$35M, a 21.2% decline from 2022.
  • REGENXBIO Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$28.8M, a 115% decline from 2021.
  • REGENXBIO Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $195M, a 2.48% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$35M -$6.13M -21.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$28.8M -$224M -115% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $195M -$4.96M -2.48% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $200M +$192M +2290% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $8.38M -$196M -95.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $204M +$120M +142% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $84.6M +$84.5M +70991% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $119K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.